TMCnet News
Transgenomic to Hold Second Quarter Financial Results Conference Call on August 6, 2014OMAHA, Neb. --(Business Wire)-- Transgenomic, Inc. (NASDAQ:TBIO) today announced the following Webcast:
To access the call via telephone, dial 866-952-1908 from the U.S. and Canada or 785-424-1827 for international participants and enter conference ID TRANS. A telephone replay will be available from 8:00 p.m. Eastern Time on August 6, 2014 through 11:59 p.m. Eastern Time on August 20, 2014 by dialing 800-723-1517 (domestic) or 402-220-2659 (international). About Transgenomic, Inc. Transgenomic, Inc. is a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through advanced diagnostic technologies, such as its revolutionary ICE COLD-PCR (News - Alert)TM and its unique genetic tests provided through its Patient Testing business. The company also provides specialized clinical and research services to biopharmaceutical companies developing targeted therapies and sells equipment, reagents and other consumables for applications in molecular testing and cytogenetics. Transgenomic's diagnostic technologies are designed to improve medical diagnoses and patient outcomes.
|